These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Virág L Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317 [TBL] [Abstract][Full Text] [Related]
7. Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences. Mangerich A; Debiak M; Birtel M; Ponath V; Balszuweit F; Lex K; Martello R; Burckhardt-Boer W; Strobelt R; Siegert M; Thiermann H; Steinritz D; Schmidt A; Bürkle A Toxicol Lett; 2016 Feb; 244():56-71. PubMed ID: 26383629 [TBL] [Abstract][Full Text] [Related]
8. Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei. Schlesinger M; Vilchez Larrea SC; Haikarainen T; Narwal M; Venkannagari H; Flawiá MM; Lehtiö L; Fernández Villamil SH Parasit Vectors; 2016 Mar; 9():173. PubMed ID: 27007296 [TBL] [Abstract][Full Text] [Related]
9. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Virág L; Szabó C Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530 [TBL] [Abstract][Full Text] [Related]
11. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158 [TBL] [Abstract][Full Text] [Related]
12. Expression of the gene encoding poly(ADP-ribose) polymerase-1 is modulated by fibronectin during corneal wound healing. Zaniolo K; Gingras ME; Audette M; Guérin SL Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4199-210. PubMed ID: 17003407 [TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. Henning RJ; Bourgeois M; Harbison RD Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072 [TBL] [Abstract][Full Text] [Related]
14. Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress. Hegedűs C; Virág L Redox Biol; 2014; 2():978-82. PubMed ID: 25460733 [TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy. Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354 [TBL] [Abstract][Full Text] [Related]
16. Detection of PARP-1 activity based on hyperbranched-poly (ADP-ribose) polymers responsive current in artificial nanochannels. Liu Y; Fan J; Yang H; Xu E; Wei W; Zhang Y; Liu S Biosens Bioelectron; 2018 Aug; 113():136-141. PubMed ID: 29754052 [TBL] [Abstract][Full Text] [Related]
18. Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress. Oláh G; Szczesny B; Brunyánszki A; López-García IA; Gerö D; Radák Z; Szabo C PLoS One; 2015; 10(7):e0134227. PubMed ID: 26218895 [TBL] [Abstract][Full Text] [Related]
19. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities. Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948 [TBL] [Abstract][Full Text] [Related]
20. Quantification of PARP Activity in Human Tissues: Ex Vivo Assays in Blood Cells and Immunohistochemistry in Human Biopsies. Horvath EM; Zsengellér ZK; Szabo C Methods Mol Biol; 2017; 1608():19-26. PubMed ID: 28695500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]